IBD & Intestinal Disorders
News from the FDA/CDC
FDA Approves Ustekinumab Biosimilar Otulfi
This is the fourth ustekinumab biosimilar approved in the United States.
From the Journals
New Biologic Tulisokibart Beats Placebo in Ulcerative Colitis Trial
Researchers said this was the first rigorous study of a drug class with an entirely new mechanism of action that may be beneficial in other immune...
From the Journals
In Crohn’s Disease, Early Anti-TNF Levels May be Crucial
“Getting it right in induction is probably the most important part” of treating Crohn’s disease, said Dr. Miguel Regueiro.
Member Spotlight
In a Parallel Universe, “I’d Be a Concert Pianist” Says Tennessee GI
Whether it’s playing her piano, working on a sewing project, or performing a colonoscopy, Dr. Stephanie D. Pointer enjoys working with her hands...
From the Journals
Environmental Pollutants Play a Growing Role in IBD
Heavy and transition metals were associated with gut dysbiosis and overgrowth of undesirable species of microorganisms.
From the AGA Journals
Reducing Biologic Discontinuation Among Pediatric Crohn’s Patients
The reasons behind biologic discontinuation in the pediatric CD population have been poorly characterized, prompting the present study.
News from AGA
2025 Crohn’s & Colitis Congress® Abstract Submissions
The 2025 Crohn’s & Colitis Congress® is now accepting original inflammatory bowel disease (IBD)-research abstract submissions...
From the AGA Journals
Study Questions Relationship Between Crohn’s Strictures and Cancer Risk
Malignant strictures were more common among older patients with longer disease duration and frequent obstructive symptoms.
From the AGA Journals
Subcutaneous Infliximab Beats Placebo for IBD Maintenance Therapy
The safety profile of the infliximab biosimilar was comparable with that of IV infliximab, with no new safety concerns emerging during the trials...
From the AGA Journals
New Associations Identified Between IBD and Extraintestinal Manifestations
Overall, 14% of patients had at least one extraintestinal manifestation.